Sun Pharma's $3.7B Organon bid leads whale moves Jun 17

Sun Pharma's $3.7B Organon bid leads whale moves Jun 17

Wednesday's filings are led by Sun Pharma's $3.7B all-cash take-private of Organon ($14.00/sh, special meeting July 23) and the Smith family's on-record declaration that Sonic Automotive is "undervalued" with a take-private "on the table" at 42% ownership. Silver Lake filed 5 more Dell Form 4s (~95K shares, ~$38M). Cevian nudged its Smith & Nephew stake to 12.24%. PayPal CFO bought $255K in PYPL discretionary shares. Gossamer Bio completed its $181M convert exchange; final settlement June 18.

Whale Investor Holdings
2026. 6. 17. · 21:31
구독 1개 · 콘텐츠 27개
Sun Pharmaceutical's $3.7 billion all-cash bid for Organon (Nasdaq: OGN) — filed as a definitive proxy on Wednesday — tops a session that added a quantum-tech SPAC merger, a Holcim full-tender for a Peruvian cement company, three fresh activist/large-holder 13D amendments, a CFO open-market buy at PayPal, and Silver Lake's continued drip-selling of Dell. The Smith family's public declaration that Sonic Automotive shares are "undervalued" and that a take-private is "on the table" is the sharpest directional signal in the batch.

Quick scan: all items, Jun 16–17

TickerFiler / entityActionKey metricFiling date
OGNSun Pharmaceutical Holdings USADEFM14A: $3.7B all-cash take-private$14.00/sh; special meeting Jul 23Jun 17
ALOTArcline Investment Management affiliates8-K: $272M all-cash acquisition$29.00/sh; 209% premium to Apr 6 priceJun 17
SVAQ / EIGQSilicon Valley Acquisition Corp. + EigenQ8-K + 425: $3B SPAC merger~$110M gross proceeds; close Q4 2026Jun 17
CPACHolcim / Inversiones ASPI13D/A: full tender offer planned50.01% stake; any-and-all; price TBDJun 17
SAHSmith family group (OBS Family + Sonic Financial + B./D./M. Smith)13D/A (Amend. 5): 40.9%–42.3% stake; take-private under review13.2M–13.4M shares each; could exceed 50%Jun 17
SNNCevian Capital II entities via Aurora Nominees6-K: 12.24% voting stake disclosed103.7M shares; up from 12.07%Jun 17
CMTLWhite Hat Capital Partners LP13D/A (Amend. 5): 9.99% stake + debt restructure$65M sub-debt at 16%; B-4 preferred at $7.99/shJun 16
VRMMudrick Capital Management entitiesForm 4 ×2: added 15,595 shares + 15,595 warrants$7.22/sh; total 3.98M sharesJun 16
PYPLJamie Miller (CFO & COO)Form 4: 6,129 shares open-market purchase$41.53/sh; ~$255KJun 16
DELLSilver Lake (5 entities)Form 4 ×5: ~95K Class C shares sold Jun 12~$399–408/sh; ~$38M; Class B convertingJun 16
GOSSGossamer Bio8-K: $181M convert exchange completed5% 2027 → 7.5% 2030 + equity; final settlement Jun 18Jun 17
HUN / OLNOlin / Huntsman combined entity425: OlinHuntsman name confirmed; H1 2027 close$12B+ all-stock; $400M+ synergies; unchangedJun 17
ENHAApeiron Investment Group (Christian Angermayer)13D/A: 24.4% stake + private placement5.14M shares + warrants at $3.89; close ~Jun 22Jun 16
Coverage: Jun 16 13:38 UTC → Jun 17 13:00 UTC

Sun Pharma bids $14.00/sh for Organon — $3.7B, special meeting Jul 23

Organon & Co. (Nasdaq: OGN) filed its definitive merger proxy on Wednesday, formalizing Sun Pharmaceutical Holdings USA, Inc.'s offer of $14.00 per share in cash — an implied equity value of approximately $3.7 billion based on 262.6 million shares outstanding as of the June 15 record date. 1
Sun Pharmaceutical Holdings USA is an indirect subsidiary of Sun Pharmaceutical Industries Ltd., one of the largest specialty-generic pharma companies globally. The transaction carries $12 billion in committed bridge financing from Sun Pharma and requires no financing condition — the board unanimously recommends shareholders vote FOR. 1
Key deal mechanics: Morgan Stanley issued a fairness opinion on April 26, 2026 and stands to receive an advisory fee of approximately $39.4 million contingent on close. A termination fee of $120 million is payable by Organon under certain conditions. The agreement was signed April 26; the proxy was mailed June 17. Close is expected early 2027, pending HSR and other regulatory approvals. 1

Smith family eyes Sonic Automotive take-private with 42% stake

Luxury automotive showroom at night with 42% ownership stake chart overlay
Smith family's 42% Sonic Automotive stake — take-private language filed on record. AI-generated illustration.
The Smith family group — comprising OBS Family LLC, Sonic Financial Corporation, and three family members (B. Scott Smith, David Bruton Smith, Marcus G. Smith) — filed a 13D/A (Amendment No. 5) disclosing individual beneficial ownership of 40.9%–42.3% of Sonic Automotive (NYSE: SAH), a publicly traded auto dealership group. 2
The group has not purchased new shares recently — the ownership increase reflects SAH's own buybacks reducing float and thereby lifting each reporting person's percentage. But the language they chose to put on record is unambiguous:
"The Reporting Persons presently believe that the Shares are undervalued at current market prices and represent an attractive investment opportunity... such acquisitions could result in the Reporting Persons acquiring greater than 50% beneficial ownership... alternatives could include, among other things, a transaction to take the Issuer private." 2
The group's current position breaks down as: OBS Family LLC holds 9.5% (3.0 million Class A shares), Sonic Financial Corp. holds 31.2% (9.9 million Class A shares via Class B conversion). Of 31.6 million combined shares outstanding (Class A + convertible Class B), the group controls more than 40% of the effective float.

Cevian bumps Smith & Nephew stake to 12.24%

Cevian Capital II — the activist-oriented Swedish fund — disclosed a modest increase in its Smith & Nephew (NYSE: SNN) stake via a UK threshold-crossing notification (TR-1) filed June 17. 3 The threshold was crossed June 12; the issuer was notified June 16.
Cevian's indirect voting rights now stand at 103,717,469 shares = 12.235936%, up from 12.074433% at the prior notification. The master fund (Cevian Capital II Master Fund L.P.) holds 11.05%; a co-investment vehicle (Series P) holds the remaining 1.19%. All rights are held in shares — no financial instruments or synthetic exposure. 3
Cevian has been a SNN holder since at least the firm's initial Q1 2026 13F disclosure. The continued slow accumulation — without any public board demands yet on record — is consistent with Cevian's typical build-first, engage-later pattern.

Three more deals: Arcline/AstroNova, EigenQ SPAC, Holcim/CPAC tender

AstroNova (Nasdaq: ALOT), a specialty printing and data equipment company, agreed June 16 to be acquired by affiliates of Arcline Investment Management LP for $29.00 per share in cash — approximately $272 million enterprise value. 4 The bid represents a 209% premium to AstroNova's unaffected share price on April 6, 2026, and roughly 120% over the 90-day VWAP through June 16. Arcline-backed funds provide a limited guarantee with no financing condition; reciprocal termination fees are set at $9.648 million. The outside date is 150 days from June 16 (plus a 30-day extension option). Board unanimously approved; subject to shareholder vote and HSR clearance.
Silicon Valley Acquisition Corp. (Nasdaq: SVAQ) signed a definitive business combination agreement with EigenQ Inc., a quantum security and technology company, at a pro forma enterprise value of approximately $3 billion. 5 EigenQ's strategic partners include HPE, AMD, and TD SYNNEX; the company is targeting a CNSA 2.0 (Commercial National Security Algorithm Suite 2.0, the US government's post-quantum cryptography standard) procurement gate in January 2027. Expected gross proceeds to EigenQ: approximately $110 million from the SVAQ trust, PIPE, and a $12.00/share private placement. Existing EigenQ shareholders are rolling substantially all of their equity. Post-close ticker: EIGQ on Nasdaq. Target close: Q4 2026, pending S-4 effectiveness and shareholder approvals. 5
Holcim Ltd. and its Peruvian affiliate Inversiones ASPI S.A. filed a 13D/A disclosing that the Holcim Executive Committee decided on June 15 to launch a public tender offer for any and all outstanding common shares of Cementos Pacasmayo (NYSE: CPAC), a Peruvian cement producer. 6 Holcim and ASPI together currently hold 211,985,547 shares = 50.01% of 423.9 million shares outstanding. The offer price has not yet been disclosed — it will be set in subsequent tender offer materials. 6

Distressed and activist positions: CMTL, VRM, ENHA

White Hat Capital Partners LP filed a 13D/A (Amendment No. 5) on Comtech Telecommunications (Nasdaq: CMTL), detailing a heavily restructured debt and equity position. 7 White Hat holds 5.056 million shares (9.99% beneficial, capped by a blocker provision), including 4.71 million shares issuable from conversion of Series B-3 Preferred. The fund's $65 million subordinated term loans now carry a 16.0% make-whole interest rate (18% on default), with make-whole premiums of 50% before April 1, 2027 and 75% thereafter. The Series B-3 Preferred was exchanged for Series B-4 Convertible Preferred at a $7.99 per share conversion price. Lender warrants add 125,000 shares at $0.10, vesting October 2026. Financial covenants have been suspended until the 4-quarter period ending July 31, 2027. The transaction is connected to Comtech's sale of its Wavestream/Gilat assets via a $65 million Purchase Agreement. 7
Mudrick Capital Management entities bought 15,595 common shares and 15,595 warrants of Vroom (Nasdaq: VRM) on June 15 in a privately negotiated transaction. 8 9 Shares were acquired at $7.22 each; warrants at $0.01 (exercise price $60.95, expiring January 2030). Total transaction value was approximately $112,752. Mudrick's cumulative VRM position across its various funds and managed accounts now totals 3,982,846 common shares. Mudrick entities are both directors and 10% owners of Vroom.
Apeiron Investment Group Ltd. (Malta), controlled by investor Christian Angermayer, reported a 24.4% beneficial stake in Enhanced Holdings (Nasdaq: ENHA) via a 13D/A filed June 16. 10 The increase stems from a Securities Purchase Agreement signed June 14 for a private placement of 5,141,388 shares plus an equal number of warrants at a combined price of $3.89. The deal closes in two tranches: approximately 3.0 million shares around June 22, and 2.1 million more after stockholder consent is effective. Resale registration is required within 30 days of closing. 10

Insider signal: PayPal CFO buys $255K open market

Abstract fintech illustration — upward price curve in glass sphere with orbiting dollar coins, trading terminal background
PayPal CFO open-market buy: $255K discretionary purchase, no 10b5-1 plan. AI-generated illustration.
Jamie S. Miller, PayPal Holdings' (Nasdaq: PYPL) Chief Financial & Operating Officer, purchased 6,129 shares at $41.53 on June 15 — a $254,537 open-market buy, per a Form 4 filed June 16. 11 The purchase was not made under a pre-arranged 10b5-1 plan. Miller simultaneously received a one-time grant of 146,778 Performance Stock Units, with a performance period running March 1, 2029 to March 1, 2031 and payout ranging from 0% to 250% based on stock-price hurdles. After the transaction, Miller holds 80,123 common shares directly plus the PSU grant and remaining RSU tranches. 11
No other C-suite PayPal Form 4s were filed in the window. At $41.53, PYPL was trading at roughly 40% below its 52-week high — the CFO's discretionary buy at this level is a data point, though a single transaction by one officer is not a cluster signal.

Watch-list updates

Data center server racks with blue LED lighting and 5-bar declining chart overlay representing systematic divestiture
Silver Lake's 5-entity Form 4 pattern on Dell — ~95K shares sold June 12 across five separate filings. AI-generated illustration.
DELL / Silver Lake — Five Silver Lake entities filed Form 4s on June 16 covering sales on June 12: combined approximately 95,003 Class C shares sold at $399–408 per share (roughly $38 million in total proceeds). 12 Entity breakdown: SLP IV (~39,537 shares), SL SPV-2 (~34,257), SLP V DE AIV (~20,095), SLTI IV (~764), SLTI V (~345). Accompanying Class B → Class C conversions totaled approximately 131,895 shares across all five entities. Additionally, DELL director David W. Dorman sold 41,292 Class C shares on June 12 via a GRAT trust at $405–408; the trust now holds zero DELL shares. Silver Lake's combined remaining Class B position across all entities: approximately 26.87 million shares. A $3 billion debt offering (three tranches: $1B 4.750% due 2031, $750M 5.000% due 2034, $1.25B 5.250% due 2037) via Dell International L.L.C. and EMC was filed as an 8-K on June 16. A 13D/A #15 remains due approximately June 20. 12
GOSS / D.E. Shaw settlement — Gossamer Bio (Nasdaq: GOSS) announced the final results of its convertible note exchange on June 17. 13 $181,052,000 of 5.00% Convertible Senior Notes due 2027 were tendered (90.5% of the $200 million outstanding after the minimum condition was amended from 98% to 90.5%). These are being exchanged for: up to $72 million of new 7.50% Convertible Senior Secured First Lien Notes due 2030, plus up to 317,647,058 common shares (or pre-funded warrants), plus early-tender warrants. The remaining $18,948,000 of old notes stays outstanding. Final settlement is June 18 — the deadline cited in the prior watch-list. A special stockholder meeting to approve related proposals is set for July 14, 2026. 13
OLN / HUN — OlinHuntsman — Huntsman filed a 425 on Wednesday morning (a LinkedIn post by Olin) confirming the combined company name: OlinHuntsman Corporation. No new material terms — the $12B+ all-stock exchange ratio (0.5476 Olin shares per Huntsman share), $400M+ synergies target, and H1 2027 close remain as previously announced. 14
IOT / Andreessen — No new Form 4s from Andreessen's LAMA Community Trust since June 12. Of the 4,512,974-share Form 144 block, approximately 2,256,487 shares have been sold (50%), leaving roughly 2,256,487 shares still under the plan.
NNDM / Murchinson — No Murchinson proxy materials (DEFC14A) filed as of the window close. The EGM record date is June 23 (six days out). EGM date remains July 31; 30-day exclusivity with Infinite Epigenetics runs through approximately July 15.
NRDY / CEO Cohn — No Day 5 filing as of June 17 13:00 UTC. The four-day buy streak ended at ~978,311 cumulative shares (~$978K). Whether it resumes Thursday is an open question.
BLND / Haveli — No new Form 4s from Haveli in the window (most recent: June 15). Stake remains approximately 22.5% (64.2 million shares including preferred conversion). No public board demands on record.
ROKU / Fox merger — ROKU CFO & COO Dan Jedda sold 7,000 Class A shares at $143.87 on June 15 under a pre-existing 10b5-1 plan. Post-sale direct holdings: 79,963 shares. No new 425 merger communications and no HSR filing yet for the $22B Fox deal.
PAYO / NuveiTCV-affiliated funds filed a 13D/A on June 16 disclosing a 10.2% stake in Payoneer (Nasdaq: PAYO) (34,197,116 shares as of April 30) and a Voting and Support Agreement to vote for Nuvei's $2.75B take-private at $7.40/sh. 15 No TCV transactions in the past 60 days; the HSR filing for the Nuvei deal is still pending.

Secondary items in window

Several items from the window are noted without full detail:
  • FTHM / Bed Bath & Beyond: A 425 filed June 17 references a combination to build an "end-to-end home ecosystem." The detail page was inaccessible at time of collection; no terms confirmed.
  • NVIDIA (NVDA): Filed a $25 billion multi-tranche investment-grade notes offering (424B5, June 16) across maturities from 2028 to 2056. Not a position disclosure.
  • LPRO / Open Lending: Bregal-backed buyout at $3.15/share (13D/A filed June 16). Terms not fully verified at time of collection.
  • MBAV / M3-Brigade: Filed a 13D/A on June 16 disclosing it dropped the ReserveOne merger and is seeking a 12-month SPAC extension.
Cover: AI-generated illustration — institutional pre-market intelligence theme.

이 콘텐츠를 둘러싼 관점이나 맥락을 계속 보강해 보세요.

  • 로그인하면 댓글을 작성할 수 있습니다.